GSC
DRTS icon

Grey Street Capital’s Alpha Tau Medical DRTS Stock Holding History

Grey Street Capital’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$68.8K Hold
23,323
– – 0.01% 485
2023
Q4 		$70.2K Hold
23,323
– – 0.03% 135
2023
Q3 		$88.4K Hold
23,323
– – 0.05% 122
2023
Q2 		$102K Buy
+23,323
New +$83.6K 0.05% 127

Other funds holding DRTS

LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
SAM
Satovsky Asset Management New York $627M AUM 19.75% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grey Street Capital's DRTS Position: Q1 2024 in Review

Grey Street Capital held its Alpha Tau Medical (DRTS) position steady in Q1 2024 at 23,323 shares worth $68.8K. The position accounts for 0.01% of the portfolio, ranked #485.

Grey Street Capital first reported a position in DRTS in Q2 2023 and has held it in 4 quarters since. The position peaked at $102K in Q2 2023. 27 funds tracked by Wall St. Rank hold DRTS as of Q1 2024.

  • Grey Street Capital held 23,323 shares of Alpha Tau Medical worth $68.8K as of Q1 2024.
  • Grey Street Capital left its Alpha Tau Medical share count unchanged in Q1 2024.
  • Alpha Tau Medical made up 0.01% of Grey Street Capital's portfolio in Q1 2024, its #485 holding.
  • Grey Street Capital first reported a position in Alpha Tau Medical in Q2 2023 and has held it in 4 quarters since.
  • Grey Street Capital's Alpha Tau Medical position peaked at $102K in Q2 2023.
  • 27 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.